FIBRYGA 1g powder + solvent for injection / infusion solution medication leaflet

B02BB01 human fibrinogen • Blood and blood forming organs | Vitamin k and other hemostatics | Fibrinogen


Human fibrinogen is an essential blood protein used as a medication to treat or prevent bleeding in patients with fibrinogen deficiency, a rare condition that can be congenital or acquired. Fibrinogen plays a crucial role in blood clotting, helping to form the clots needed to stop bleeding.

Human fibrinogen is administered by intravenous infusion under the strict supervision of medical personnel. The dose and frequency of administration are determined by the doctor, depending on the severity of the deficiency and the patient's needs. Careful monitoring is essential to prevent complications.

Possible side effects include allergic reactions, fever, chills, or an increased risk of blood clots. In rare cases, severe reactions such as anaphylactic shock may occur. If you experience any unusual symptoms, contact your doctor immediately.

Human fibrinogen is vital for patients with bleeding disorders, but its use requires careful medical supervision. Inform your doctor about any other conditions or treatments you are undergoing to reduce the risk of complications.

General data about FIBRYGA 1g

Substance: human fibrinogen

Date of last drug list: 01-06-2025

Commercial code: W67066002

Concentration: 1g

Pharmaceutical form: powder + solvent for injection / infusion solution

Quantity: 1

Product type: original

Price: 2178.46 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M.B.H. - AUSTRIA

Holder: OCTAPHARMA (IP) SPRL - BELGIA

Number: 14395/2022/01

Shelf life: 3 years-after packaging for sale;after reconstitution-24h

Compensation lists for FIBRYGA 1g OCTAPHARMA

NHP 6.14 (C2) - Congenital afibrinogenemia

Price

Copayment

Patient

2178.46 RON

2178.46 RON

0.00 RON